APO RESEARCH · REPORT
Levonorgestrel
Levonorgestrel is a hormonal medication which is used in a number of birth control methods. In pill form, sold under the brand name Plan B among others, it is useful within 120 hours as emergency birth control. It becomes less effective the longer after sex and only works before pregnancy has occurred. It is also combined with an estrogen to make Mixture Products. Within an intrauterine device (IUD), sold as Mirena among others, it is effective for long-term prevention of pregnancy. An implantable form of levonorgestrel is also available in some countries.
Product & engineering
Understand the product.
Levonorgestrel is a hormonal medication which is used in a number of birth control methods. In pill form, sold under the brand name Plan B among others, it is useful within 120 hours as emergency birth control. It becomes less effective the longer after sex and only works before pregnancy has occurred. It is also combined with an estrogen to make Mixture Products. Within an intrauterine device (IUD), sold as Mirena among others, it is effective for long-term prevention of pregnancy. An implantable form of levonorgestrel is also available in some countries.
Selected research
Industry Research
Levonorgestrel Industry Research Report 2026
Market perspective
Levonorgestrel is a hormonal medication which is used in a number of birth control methods. In pill form, sold under the brand name Plan B among others, it is useful within 120 hours as emergency birth control. It becomes less effective the longer after sex and only works before pregnancy has occurred. It is also combined with an estrogen to make Mixture Products. Within an intrauterine device (IUD), sold as Mirena among others, it is effective for long-term prevention of pregnancy. An implantable form of levonorgestrel is also available in some countries.
Europe is the largest Levonorgestrel market with about 43% market share. Asia-Pacific is follower, accounting for about 29% market share.The key manufacturers are Bayer, Paladin Labs, Foundation Consumer Healthcare, Theramex (Teva), Pfizer, Apotex, HRA Pharma etc. Top 3 companies occupied about 68% market share.
Report Scope
Read the full market overview
This report quantifies the global Levonorgestrel market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Levonorgestrel Market by Company
Bayer
Paladin Labs
Foundation Consumer Healthcare
Theramex (Teva)
Pfizer
Apotex
HRA Pharma
Levonorgestrel Segment by Type
Levonorgestrel Table
Mixture Products
Hormone-releasing IUD
Levonorgestrel Segment by Application
Hospital
Drug Store
Online Sale
Levonorgestrel Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Levonorgestrel market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Levonorgestrel and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Levonorgestrel.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Levonorgestrel manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Levonorgestrel by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Levonorgestrel in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Levonorgestrel Table
- Mixture Products
- Hormone-releasing IUD
Applications
- Hospital
- Drug Store
- Online Sale
Companies covered
- Bayer
- Paladin Labs
- Foundation Consumer Healthcare
- Theramex (Teva)
- Pfizer
- Apotex
- HRA Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Levonorgestrel Market Size (2021-2032)
- 2.2.2 Global Levonorgestrel Sales (2021-2032)
- 2.2.3 Global Levonorgestrel Market Average Price (2021-2032)
- 2.3 Levonorgestrel by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Levonorgestrel Table
- 2.3.3 Mixture Products
- 2.3.4 Hormone-releasing IUD
- 2.4 Levonorgestrel by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Drug Store
- 2.4.4 Online Sale
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Levonorgestrel Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Levonorgestrel Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Levonorgestrel Revenue of Manufacturers (2021-2026)
- 3.4 Global Levonorgestrel Average Price by Manufacturers (2021-2026)
- 3.5 Global Levonorgestrel Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Levonorgestrel, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Levonorgestrel, Product Type & Application
- 3.8 Global Manufacturers of Levonorgestrel, Established Date
- 3.9 Global Levonorgestrel Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Bayer
- 4.1.1 Bayer Company Information
- 4.1.2 Bayer Business Overview
- 4.1.3 Bayer Levonorgestrel Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Bayer Levonorgestrel Product Portfolio
- 4.1.5 Bayer Recent Developments
- 4.2 Paladin Labs
- 4.2.1 Paladin Labs Company Information
- 4.2.2 Paladin Labs Business Overview
- 4.2.3 Paladin Labs Levonorgestrel Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Paladin Labs Levonorgestrel Product Portfolio
- 4.2.5 Paladin Labs Recent Developments
- 4.3 Foundation Consumer Healthcare
- 4.3.1 Foundation Consumer Healthcare Company Information
- 4.3.2 Foundation Consumer Healthcare Business Overview
- 4.3.3 Foundation Consumer Healthcare Levonorgestrel Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Foundation Consumer Healthcare Levonorgestrel Product Portfolio
- 4.3.5 Foundation Consumer Healthcare Recent Developments
- 4.4 Theramex (Teva)
- 4.4.1 Theramex (Teva) Company Information
- 4.4.2 Theramex (Teva) Business Overview
- 4.4.3 Theramex (Teva) Levonorgestrel Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Theramex (Teva) Levonorgestrel Product Portfolio
- 4.4.5 Theramex (Teva) Recent Developments
- 4.5 Pfizer
- 4.5.1 Pfizer Company Information
- 4.5.2 Pfizer Business Overview
- 4.5.3 Pfizer Levonorgestrel Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Pfizer Levonorgestrel Product Portfolio
- 4.5.5 Pfizer Recent Developments
- 4.6 Apotex
- 4.6.1 Apotex Company Information
- 4.6.2 Apotex Business Overview
- 4.6.3 Apotex Levonorgestrel Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Apotex Levonorgestrel Product Portfolio
- 4.6.5 Apotex Recent Developments
- 4.7 HRA Pharma
- 4.7.1 HRA Pharma Company Information
- 4.7.2 HRA Pharma Business Overview
- 4.7.3 HRA Pharma Levonorgestrel Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 HRA Pharma Levonorgestrel Product Portfolio
- 4.7.5 HRA Pharma Recent Developments
5 Global Levonorgestrel Market Scenario by Region
- 5.1 Global Levonorgestrel Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Levonorgestrel Sales by Region: 2021-2032
- 5.2.1 Global Levonorgestrel Sales by Region: 2021-2026
- 5.2.2 Global Levonorgestrel Sales by Region: 2027-2032
- 5.3 Global Levonorgestrel Revenue by Region: 2021-2032
- 5.3.1 Global Levonorgestrel Revenue by Region: 2021-2026
- 5.3.2 Global Levonorgestrel Revenue by Region: 2027-2032
- 5.4 North America Levonorgestrel Market Facts & Figures by Country
- 5.4.1 North America Levonorgestrel Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Levonorgestrel Sales by Country (2021-2032)
- 5.4.3 North America Levonorgestrel Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Levonorgestrel Market Facts & Figures by Country
- 5.5.1 Europe Levonorgestrel Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Levonorgestrel Sales by Country (2021-2032)
- 5.5.3 Europe Levonorgestrel Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Levonorgestrel Market Facts & Figures by Country
- 5.6.1 Asia Pacific Levonorgestrel Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Levonorgestrel Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Levonorgestrel Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Levonorgestrel Market Facts & Figures by Country
- 5.7.1 South America Levonorgestrel Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Levonorgestrel Sales by Country (2021-2032)
- 5.7.3 South America Levonorgestrel Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Levonorgestrel Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Levonorgestrel Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Levonorgestrel Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Levonorgestrel Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Levonorgestrel Sales by Type (2021-2032)
- 6.1.1 Global Levonorgestrel Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Levonorgestrel Sales Market Share by Type (2021-2032)
- 6.2 Global Levonorgestrel Revenue by Type (2021-2032)
- 6.2.1 Global Levonorgestrel Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Levonorgestrel Revenue Market Share by Type (2021-2032)
- 6.3 Global Levonorgestrel Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Levonorgestrel Sales by Application (2021-2032)
- 7.1.1 Global Levonorgestrel Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Levonorgestrel Sales Market Share by Application (2021-2032)
- 7.2 Global Levonorgestrel Revenue by Application (2021-2032)
- 7.2.1 Global Levonorgestrel Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Levonorgestrel Revenue Market Share by Application (2021-2032)
- 7.3 Global Levonorgestrel Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Levonorgestrel Value Chain Analysis
- 8.1.1 Levonorgestrel Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Levonorgestrel Production Mode & Process
- 8.2 Levonorgestrel Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Levonorgestrel Distributors
- 8.2.3 Levonorgestrel Customers
9 Global Levonorgestrel Analyzing Market Dynamics
- 9.1 Levonorgestrel Industry Trends
- 9.2 Levonorgestrel Industry Drivers
- 9.3 Levonorgestrel Industry Opportunities and Challenges
- 9.4 Levonorgestrel Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst